Revvity (RVTY) Net Cash Flow Growth (5y) (2014 - 2026)
Revvity (RVTY) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -15.86% |
| Dec 28, 2025 | 23.49% |
| Sep 28, 2025 | -40.39% |
| Jun 29, 2025 | -62.19% |
| Mar 30, 2025 | -38.61% |
| Dec 29, 2024 | 17.28% |
| Sep 29, 2024 | -17.61% |
| Jun 30, 2024 | 52.91% |
| Mar 31, 2024 | 39.63% |
| Dec 31, 2023 | -97.85% |
| Oct 1, 2023 | -76.33% |
| Jul 2, 2023 | -145.46% |
| Apr 2, 2023 | -60.05% |
| Jan 1, 2023 | 27.78% |
| Apr 3, 2022 | 26.36% |
| Apr 4, 2021 | 77.14% |
| Oct 4, 2020 | 27.66% |
| Jul 5, 2020 | -0.79% |
| Apr 5, 2020 | 27.86% |
| Dec 29, 2019 | -88.73% |